Sarepta Therapeutics (SRPT) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 4, 2026, to be held virtually at 10:00 AM EDT.

• Proxy materials and annual report are available online for review and voting.

• Shareholders are encouraged to vote online or request paper copies of materials by May 26, 2026.

Voting matters and shareholder proposals

• Election of five Class I director nominees to serve until the 2028 annual meeting.

• Advisory vote on executive officer compensation (say-on-pay) on a non-binding basis.

• Approval of the 2026 Equity Incentive Plan.

• Approval of the 2026 Employee Stock Purchase Plan.

• Ratification of KPMG LLP as independent registered public accounting firm for the year ending December 31, 2026.

Board of directors and corporate governance

• Board recommends voting "FOR" all director nominees and all proposals listed.

• Director nominees include Douglas S. Ingram, Hans Wigzell, Kathryn J. Boor, Michael Chambers, and Deirdre Connelly.